PubMed Health⌕ Search

PubMed · 14502479

Predictive toxicology: benchmarking molecular descriptors and statistical methods.

Abstract

The development of drugs depends on finding compounds that have beneficial effects with a minimum of toxic effects. The measurement of toxic effects is typically time-consuming and expensive, so there is a need to be able to predict toxic effects from the compound structure. Predicting toxic effects is expected to be challenging because there are usually multiple toxic mechanisms involved. In this paper, combinations of different chemical descriptors and popular statistical methods were applied to the problem of predictive toxicology. Four data sets were collected and cleaned, and four different sets of chemical descriptors were calculated for the compounds in each of the four data sets. Three statistical methods (recursive partitioning, neural networks, and partial least squares) were used to attempt to link chemical descriptors to the response. Good predictions were achieved in the two smaller data sets; we found for large data sets that the results were less effective, indicating that new chemical descriptors or statistical methods are needed. All of the methods and descriptors worked to a degree, but our work hints that certain descriptors work better with specific statistical methods so there is a need for better understanding and for continued methods development.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jun Feng, Laura Lurati, Haojun Ouyang, Tracy Robinson, Yuanyuan Wang, Shenglan Yuan, S Stanley Young. Predictive toxicology: benchmarking molecular descriptors and statistical methods.. https://doi.org/10.1021/ci034032s

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study.

The p38 protein kinase is a serine-threonine mitogen activated protein kinase, which plays an important role in inflammation and arthritis. A combined study of 3D-QSAR and molecular docking has been undertaken to explore the structural insights of pyrazolyl urea p38 kinase inhibitors. The 3D-QSAR studies involved comparative molecular field analysis (CoMFA) and comparative molecular similarity indices (CoMSIA). The best CoMFA model was derived from the atom fit alignment with a cross-validated r (2 )(q (2)) value of 0.516 and conventional r (2) of 0.950, while the best CoMSIA model yielded a q (2) of 0.455 and r (2) of 0.979 (39 molecules in training set, 9 molecules in test set). The CoMFA and CoMSIA contour maps generated from these models provided inklings about the influence of interactive molecular fields in the space on the activity. GOLD, Sybyl (FlexX) and AutoDock docking protocols were exercised to explore the protein-inhibitor interactions. The integration of 3D-QSAR and molecular docking has proffered essential structural features of pyrazolyl urea inhibitors and also strategies to design new potent analogues with enhanced activity.

Drug Design↗